Skip to main content

Want a detailed portfolio tracker?

Revelation Biosciences (REVB) P/E (2024 - 2026)

Revelation Biosciences (REVB) P/E from Apr 1, 2024 to Jun 3, 2026. The TTM Revelation Biosciences (REVB) P/E is -0.22. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Revelation Biosciences (REVB)

YearP/EChange
2026-0.22-29.18%
2025-0.32-82.41%
2024-1.79N/A

Comparison Revelation Biosciences (REVB) P/E with competitors

Revelation Biosciences (REVB) P/E is -0.22.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.76%
NBYStablecoin Development Corp0.10-145.81%
ENLVEnlivex Therapeutics Ltd0.15-167.31%
FGENFibroGen Inc0.24-207.56%
TRAWTraws Pharma Inc0.47-311.86%
FBIOFortress Biotech Inc0.71-416.36%
CHRSCoherus Biosciences Inc0.98-538.29%
ORMPOramed Pharmaceuticals Inc1.47-760.24%
AGENAgenus Inc2.05-1017.90%
VIVSVivoSim Labs Inc2.54-1236.26%
INVAInnoviva Inc3.19-1528.73%
CRMDCorMedix Inc3.65-1733.61%
ABEOAbeona Therapeutics Inc4.20-1984.23%
VXRTVaxart Inc4.26-2009.59%
CVACCureVac N.V.4.45-2092.04%
SRPTSarepta Therapeutics Inc4.62-2172.08%
GLPGGalapagos NV4.86-2277.20%
RIGLRigel Pharmaceuticals4.92-2304.40%
ZVRAZevra Therapeutics Inc4.97-2328.82%
ABUSArbutus Biopharma Corp5.69-2651.32%
CGENCompugen Ltd7.38-3408.71%
AUPHAurinia Pharmaceuticals Inc9.25-4245.54%
ACADAcadia Pharmaceuticals Inc9.59-4396.37%
OMEROmeros Corporation9.88-4528.74%
PLXProtalix BioTherapeutics Inc9.91-4540.26%
SPROSpero Therapeutics Inc10.73-4910.21%
ADMAAdma Biologics Inc11.33-5177.24%
SVASinovac Biotech Ltd11.44-5224.47%
TBPHTheravance Biopharma Inc11.78-5377.09%
HRMYHarmony Biosciences Holdings Inc12.18-5558.04%
TGTXTG Therapeutics Inc13.18-6005.69%
INCYIncyte Corp13.38-6096.48%
SABSSAB Biotherapeutics Inc14.06-6399.26%
XOMAXOMA Corp14.95-6796.95%
REGNRegeneron Pharmaceuticals Inc14.98-6812.64%
PBYIPuma Biotechnology Inc15.05-6844.09%
EXELExelixis Inc15.79-7177.66%
NAGENiagen Bioscience Inc16.35-7428.64%
CPRXCatalyst Pharmaceuticals Inc17.34-7872.18%
MDXGMimedx Group Inc17.38-7885.89%
ARGXArgen X SE23.07-10438.38%
HALOHalozyme Therapeutics Inc23.20-10496.18%
XOMAOXOMA Corp25.34-11457.01%
VRTXVertex Pharmaceuticals Inc25.66-11596.37%
XOMAPXOMA Corp25.67-11602.77%
CTMXCytomX Therapeutics Inc25.70-11615.23%
ASNDAscendis Pharma A/S26.35-11909.28%
RPRXRoyalty Pharma plc - Class A27.50-12420.70%
SLNOSoleno Therapeutics Inc29.02-13101.77%
LGNDLigand Pharmaceuticals Inc - Class B30.19-13626.59%
BMRNBiomarin Pharmaceutical Inc37.51-16907.02%
APLSApellis Pharmaceuticals Inc39.02-17585.40%
KRYSKrystal Biotech Inc39.70-17888.50%
GMABGenmab40.20-18115.24%
ONCBeiGene Ltd67.03-30134.81%
TECHBio-Techne Corp68.59-30837.48%
VCELVericel Corp80.63-36230.01%
PHARPharming Group N.V.87.74-39416.43%
ALNYAlnylam Pharmaceuticals Inc124.93-56082.88%
TLXTelix Pharmaceuticals Ltd139.89-62785.12%
CORTCorcept Therapeutics Inc158.39-71074.36%